Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
dc.contributor.author | Chen, Junjie | |
dc.contributor.author | Silver, Daniel P. | |
dc.contributor.author | Walpita, Deepika | |
dc.contributor.author | Cantor, Sharon B. | |
dc.contributor.author | Gazdar, Adi F. | |
dc.contributor.author | Tomlinson, Gail | |
dc.contributor.author | Couch, Fergus J. | |
dc.contributor.author | Weber, Barbara L. | |
dc.contributor.author | Ashley, Terry | |
dc.contributor.author | Livingston, David M. | |
dc.contributor.author | Scully, Ralph | |
dc.date | 2022-08-11T08:08:02.000 | |
dc.date.accessioned | 2022-08-23T15:40:01Z | |
dc.date.available | 2022-08-23T15:40:01Z | |
dc.date.issued | 1998-10-17 | |
dc.date.submitted | 2008-12-10 | |
dc.identifier.citation | Mol Cell. 1998 Sep;2(3):317-28. | |
dc.identifier.issn | 1097-2765 (Print) | |
dc.identifier.pmid | 9774970 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/26308 | |
dc.description.abstract | BRCA1 and BRCA2 account for most cases of familial, early onset breast and/or ovarian cancer and encode products that each interact with hRAD51. Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. Like BRCA1 and RAD51, BRCA2 relocates to PCNA+ replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. Thus, BRCA1 and BRCA2 participate, together, in a pathway(s) associated with the activation of double-strand break repair and/or homologous recombination. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=9774970&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1016/S1097-2765(00)80276-2 | |
dc.subject | Antibodies, Monoclonal | |
dc.subject | BRCA1 Protein | |
dc.subject | BRCA2 Protein | |
dc.subject | Breast Neoplasms | |
dc.subject | Cell Line | |
dc.subject | Cell Nucleus | |
dc.subject | Chromosome Mapping | |
dc.subject | DNA Damage | |
dc.subject | DNA Repair | |
dc.subject | DNA Replication | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Female | |
dc.subject | *Genes, BRCA1 | |
dc.subject | *Genes, Tumor Suppressor | |
dc.subject | Humans | |
dc.subject | Meiosis | |
dc.subject | Mitosis | |
dc.subject | Neoplasm Proteins | |
dc.subject | Ovarian Neoplasms | |
dc.subject | Rad51 Recombinase | |
dc.subject | Transcription Factors | |
dc.subject | Transfection | |
dc.subject | Tumor Cells, Cultured | |
dc.subject | Zygote | |
dc.subject | Cancer Biology | |
dc.subject | Neoplasms | |
dc.title | Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells | |
dc.type | Journal Article | |
dc.source.journaltitle | Molecular cell | |
dc.source.volume | 2 | |
dc.source.issue | 3 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/cancerbiology_pp/7 | |
dc.identifier.contextkey | 679285 | |
html.description.abstract | <p>BRCA1 and BRCA2 account for most cases of familial, early onset breast and/or ovarian cancer and encode products that each interact with hRAD51. Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. Like BRCA1 and RAD51, BRCA2 relocates to PCNA+ replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. Thus, BRCA1 and BRCA2 participate, together, in a pathway(s) associated with the activation of double-strand break repair and/or homologous recombination. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer.</p> | |
dc.identifier.submissionpath | cancerbiology_pp/7 | |
dc.contributor.department | Department of Cancer Biology | |
dc.source.pages | 317-28 |